Recent Updates
Recently added Catalysts
CGEM

Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Key Takeaway: Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+93%
120-day peak, hindsight
Typical move
6.7%
average across 8 past catalysts
Cash runway
~26 mo
Minimal dilution risk
Lead asset
CLN-619
Phase 1 · Multiple Myeloma

Full Press Release Details

Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares.
Last updated: Jan 12, 2021